IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Ask Genius
Apps
News
Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars
Brands
Yourlist
Quizie
F
FaithTap
B
Blessed
All brands
Ask Genius
Apps
Trending
Israeli Hostage Rescued From Gaza Tunnel In Complex Operation
x/the-gaza-strip
— Sep 4, 2024
Qaid Farhan al-Qadi with his brother at Soroka Medical Center following his rescue from Gaza. COURTESY “> Israel Defense Forces troops on Tuesday rescued an Israeli hostage Qaid Farhan al-Qadi from an underground tunnel…
Share
NeuroThera advances enrollment in SCI-210 autism trial toward 60-participant goal
x/soroka-medical-center
— Aug 31, 2026
NeuroThera Labs’ SCI-210, a CBD-CannAmide formulation for autism, is advancing in a double-blind trial at Soroka Medical Center in Israel, with enrollment moving toward 60 participants and early momentum reported (six in Article 1, 26 by mid-trial updates in Articles 2 and 3) and endpoints including the ABC-C and CGI-I assessments. The program, conducted under NeuroThera as a SciSparc subsidiary, aims to determine whether SCI-210 offers advantages over CBD alone, with plans to commercialize initially in Israel if successful.
+3
3
Share
Chris Dalton
Commercializing in Israel first makes sense before trying to scale anywhere else, smart move if the data holds up.